Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21f23f0c43864bd4d632cd6023e4a66a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcff13f8573db698307f919e6385d5c4 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-30 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-30 |
filingDate |
1995-09-11^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1999-06-15^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a635904bf135ec9bb31457d3703894e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c56d84144ad87acb3b59668d586f631a |
publicationDate |
1999-06-15^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5912356-A |
titleOfInvention |
Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring |
abstract |
PCT No. PCT/US95/11366 Sec. 371 Date Apr. 7, 1997 Sec. 102(e) Date Apr. 7, 1997 PCT Filed Sep. 11, 1995 PCT Pub. No. WO96/07646 PCT Pub. Date Mar. 14, 1996Antiviral purine nucleoside analogues contain a substituted benzimidazole base attached to a carbocyclic ring in place of the conventional sugar residue. Methods of treating herpes viral infections and pharmaceutical formulations are also described. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009036678-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9802938-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8933225-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10745404-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6479241-B1 |
priorityDate |
1995-09-11^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |